The greater room for improvement in skin showing more advanced aging signs means potential for more dramatic results with appropriate products and patience
Repeated freeze-thaw cycles degrade the peptide
Which GLP-1 medications carry the highest risk Not all GLP-1 medications are created equal when it comes to hair loss risk
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
In one trial, artichoke extract (1,800 mg/day) for six weeks reduced total cholesterol (-9.9%) and LDL cholesterol (-16.6%) in 71 hypercholesterolemic patients, with no differences in HDL cholesterol or triglycerides
In addition to these factors, aging and obesity are also considered as endogenous risk factors